Under the terms of the collaboration, Iktos will apply its generative AI and AI-orchestrated robotics platform to design, ...
For more than 50 years, scientists have sought alternatives to silicon for building molecular electronics. The vision was elegant; the reality proved far more complex. Within a device, molecules ...
Variational AI, a Vancouver-based Healthcare Tech Company, advances Generative AI Drug Discovery by designing novel small ...
A little more than a year after announcing plans for its molecule design programs to set up shop in the field of generative AI, Nvidia is opening its doors. Just as call-and-response apps like ChatGPT ...
Researchers at Kumamoto University, in collaboration with colleagues in South Korea and Taiwan, have discovered that a unique ...
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--insitro, a pioneer in machine learning for drug discovery and development, today announced a new collaboration with Eli Lilly and Company (Lilly) to ...
REHOVOT, Israel, Oct. 31, 2024 /PRNewswire/ -- Evogene Ltd. (NASDAQ: EVGN) (TASE: EVGN), a leading computational biology company aiming to revolutionize life-science-based product discovery and ...
Our goal with CosmeticAI™ was to make cosmetic ingredient development predictable rather than exploratory” — Dr. Lurong Pan, CEO of Ainnocence SAN FRANSICO, CA, UNITED STATES, January 1, 2026 ...
Molecular electronics is a branch of nanotechnology that focuses on using individual molecules or nanoscale molecular structures as electronic components to create miniaturized circuits and devices.
Discover how Optibrium is transforming early-stage drug discovery through AI-powered software, generative chemistry, and 3D modelling. In this interview, Matt Segall, CEO at Optibrium, shares insights ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback